Correction: A Cationic-Independent Mannose 6-Phosphate Receptor Inhibitor (PXS64) Ameliorates Kidney Fibrosis by Inhibiting Activation of Transforming Growth Factor-β1.

After publication of this article [[1]], the authors notified I PLOS ONE i that the incorrect image was used in the UUO+PXS64 panel of Fig 4. Pre-treatment with telmisartan (UUO +telmisartan) or administration of PXS64 (UUO+PXS64) on the same day of UUO procedure significantly reduced the tubulointerstitial fibrosis score. Graph: Fig 4 Animals treated with PXS64 showed reduced tubulointerstitial fibrosis in the unilateral ureteric obstruction (UUO) model. [Extracted from the article]